Non-Coding Variants in BRCA1 and BRCA2 Genes: Potential Impact on Breast and Ovarian Cancer Predisposition
出版年份 2018 全文链接
标题
Non-Coding Variants in BRCA1 and BRCA2 Genes: Potential Impact on Breast and Ovarian Cancer Predisposition
作者
关键词
-
出版物
Cancers
Volume 10, Issue 11, Pages 453
出版商
MDPI AG
发表日期
2018-11-17
DOI
10.3390/cancers10110453
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Genetic dissection of the BRCA2 promoter and transcriptional impact of DNA variants
- (2018) Eugenia Fraile-Bethencourt et al. BREAST CANCER RESEARCH AND TREATMENT
- A systematic review on the frequency of BRCA promoter methylation in breast and ovarian carcinomas of BRCA germline mutation carriers: Mutually exclusive, or not?
- (2018) Shoko Vos et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- No Evidence for the Pathogenicity of the BRCA2 c.6937 + 594T>G Deep Intronic Variant: A Case–Control Analysis
- (2018) Julie Dutil et al. Genetic Testing and Molecular Biomarkers
- Landscape of pathogenic variations in a panel of 34 genes and cancer risk estimation from 5131 HBOC families
- (2018) Laurent Castéra et al. GENETICS IN MEDICINE
- Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial
- (2018) Andrew Tutt et al. NATURE MEDICINE
- A Dominantly Inherited 5′ UTR Variant Causing Methylation-Associated Silencing of BRCA1 as a Cause of Breast and Ovarian Cancer
- (2018) D.Gareth R. Evans et al. AMERICAN JOURNAL OF HUMAN GENETICS
- BRCA1 and BRCA2 5′ noncoding region variants identified in breast cancer patients alter promoter activity and protein binding
- (2018) Leslie J. Burke et al. HUMAN MUTATION
- Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma
- (2018) Olga Kondrashova et al. Nature Communications
- Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
- (2018) Kathleen Moore et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
- (2017) Karoline B. Kuchenbaecker et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Robert L Coleman et al. LANCET
- Novel insights into chromosomal conformations in cancer
- (2017) Ruobing Jia et al. Molecular Cancer
- Association analysis identifies 65 new breast cancer risk loci
- (2017) Kyriaki Michailidou et al. NATURE
- Fast, scalable prediction of deleterious noncoding variants from functional and population genomic data
- (2017) Yi-Fei Huang et al. NATURE GENETICS
- Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
- (2017) Mark Robson et al. NEW ENGLAND JOURNAL OF MEDICINE
- A unified analytic framework for prioritization of non-coding variants of uncertain significance in heritable breast and ovarian cancer
- (2016) Eliseos J. Mucaki et al. BMC Medical Genomics
- Mutation screening of MIR146A/B and BRCA1/2 3′-UTRs in the GENESIS study
- (2016) Amandine I Garcia et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Structure of BRCA1-BRCT/Abraxas Complex Reveals Phosphorylation-Dependent BRCT Dimerization at DNA Damage Sites
- (2016) Qian Wu et al. MOLECULAR CELL
- Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
- (2016) Mansoor R. Mirza et al. NEW ENGLAND JOURNAL OF MEDICINE
- A second DNA binding site in human BRCA2 promotes homologous recombination
- (2016) Catharina von Nicolai et al. Nature Communications
- Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus
- (2016) Kate Lawrenson et al. Nature Communications
- Post-transcriptional Regulation of BRCA2 through Interactions with miR-19a and miR-19b
- (2016) Elena Mogilyansky et al. Frontiers in Genetics
- Molding BRCA2 function through its interacting partners
- (2015) Juan S Martinez et al. CELL CYCLE
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
- (2015) Sue Richards et al. GENETICS IN MEDICINE
- Non-coding genetic variants in human disease: Figure 1.
- (2015) Feng Zhang et al. HUMAN MOLECULAR GENETICS
- Predicting effects of noncoding variants with deep learning–based sequence model
- (2015) Jian Zhou et al. NATURE METHODS
- Genome-wide map of regulatory interactions in the human genome
- (2014) Nastaran Heidari et al. GENOME RESEARCH
- A general framework for estimating the relative pathogenicity of human genetic variants
- (2014) Martin Kircher et al. NATURE GENETICS
- Analysis of hundreds of cis-regulatory landscapes at high resolution in a single, high-throughput experiment
- (2014) Jim R Hughes et al. NATURE GENETICS
- Expression Defect Size among Unclassified MLH1 Variants Determines Pathogenicity in Lynch Syndrome Diagnosis
- (2013) I. Hinrichsen et al. CLINICAL CANCER RESEARCH
- Large-scale genotyping identifies 41 new loci associated with breast cancer risk
- (2013) Kyriaki Michailidou et al. NATURE GENETICS
- TERT Promoter Mutations in Familial and Sporadic Melanoma
- (2013) S. Horn et al. SCIENCE
- The Role of Telomere Biology in Cancer
- (2012) Lifeng Xu et al. Annual Review of Pathology-Mechanisms of Disease
- BRCA2 Deep Intronic Mutation Causing Activation of a Cryptic Exon: Opening toward a New Preventive Therapeutic Strategy
- (2012) O. Anczukow et al. CLINICAL CANCER RESEARCH
- Identification of constitutional MLH1 epimutations and promoter variants in colorectal cancer patients from the Colon Cancer Family Registry
- (2012) Robyn L. Ward et al. GENETICS IN MEDICINE
- Identification of fifteen novel germline variants in theBRCA13′UTR reveals a variant in a breast cancer case that introduces a functionalmiR-103target site
- (2012) Brooke L. Brewster et al. HUMAN MUTATION
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
- (2012) Christina Curtis et al. NATURE
- Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
- (2012) Jonathan Ledermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dominantly Inherited Constitutional Epigenetic Silencing of MLH1 in a Cancer-Affected Family Is Linked to a Single Nucleotide Variant within the 5′UTR
- (2011) Megan P. Hitchins et al. CANCER CELL
- ENIGMA-Evidence-based network for the interpretation of germline mutant alleles: An international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes
- (2011) Amanda B. Spurdle et al. HUMAN MUTATION
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Selective 2′-hydroxyl acylation analyzed by protection from exoribonuclease (RNase-detected SHAPE) for direct analysis of covalent adducts and of nucleotide flexibility in RNA
- (2011) Kady-Ann Steen et al. Nature Protocols
- Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1/BRCA2 databases
- (2011) Sandrine Caputo et al. NUCLEIC ACIDS RESEARCH
- Two novel variants in the 3′UTR of the BRCA1 gene in familial breast and/or ovarian cancer
- (2010) Stéphanie Lheureux et al. BREAST CANCER RESEARCH AND TREATMENT
- Cell cycle-dependent regulation of the bi-directional overlapping promoter of human BRCA2/ZAR2 genes in breast cancer cells
- (2010) Smita Misra et al. Molecular Cancer
- Disease-Associated Mutations That Alter the RNA Structural Ensemble
- (2010) Matthew Halvorsen et al. PLoS Genetics
- The BRCA1 3′-UTR: 5711+421T/T_5711+1286T/T Genotype Is a Possible Breast and Ovarian Cancer Risk Factor
- (2009) Malinee Pongsavee et al. Genetic Testing and Molecular Biomarkers
- The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer
- (2009) Mark M Pomerantz et al. NATURE GENETICS
- Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery
- (2009) Jessica Kao et al. PLoS One
- The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
- (2008) A C Antoniou et al. BRITISH JOURNAL OF CANCER
- Posttranscriptional Regulation of the Breast Cancer Susceptibility Gene BRCA1 by the RNA Binding Protein HuR
- (2008) J. M. Saunus et al. CANCER RESEARCH
- Prediction and assessment of splicing alterations: implications for clinical testing
- (2008) Amanda B. Spurdle et al. HUMAN MUTATION
- Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results
- (2008) Sharon E. Plon et al. HUMAN MUTATION
- Poly(ADP-ribose) Polymerase-1 Down-regulates BRCA2 Expression through theBRCA2Promoter
- (2008) Jinhua Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started